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Abstract
Large animal models are an important resource for the understanding of human disease and for evaluating the applicability
of new therapies to human patients. For many diseases, such as cone dystrophy, research effort is hampered by the lack of
such models. Lentiviral transgenesis is a methodology broadly applicable to animals from many different species. When
conjugated to the expression of a dominant mutant protein, this technology offers an attractive approach to generate new
large animal models in a heterogeneous background. We adopted this strategy to mimic the phenotype diversity encounter
in humans and generate a cohort of pigs for cone dystrophy by expressing a dominant mutant allele of the guanylate
cyclase 2D (GUCY2D) gene. Sixty percent of the piglets were transgenic, with mutant GUCY2D mRNA detected in the retina
of all animals tested. Functional impairment of vision was observed among the transgenic pigs at 3 months of age, with a
follow-up at 1 year indicating a subsequent slower progression of phenotype. Abnormal retina morphology, notably among
the cone photoreceptor cell population, was observed exclusively amongst the transgenic animals. Of particular note, these
transgenic animals were characterized by a range in the severity of the phenotype, reflecting the human clinical situation.
We demonstrate that a transgenic approach using lentiviral vectors offers a powerful tool for large animal model
development. Not only is the efficiency of transgenesis higher than conventional transgenic methodology but this
technique also produces a heterogeneous cohort of transgenic animals that mimics the genetic variation encountered in
human patients.
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Introduction
Current preclinical trials are heavily reliant on rodents,
although their usefulness as disease models may be restricted
because of major differences in body size, general physiology,
anatomy, diet or lifespan. Thus, replication of a human mutation
in mice can result in a significantly different disease phenotype, as
exemplified in the retinoblastoma [1] or cystic fibrosis [2]
transgenic mouse models. It is recognized that the efficacy of
translation of new drugs or techniques to the clinic would benefit
from evaluation and testing in large animals, which have organ
size and metabolism similar to humans [3]. There is therefore a
need to extend genetically-defined disease models beyond mice to
other species.
Somatic cell nuclear transfer (SCNT) from transgenic donor
cells has been widely used as a method for pig transgenesis, but
is technically demanding, time consuming, and typically suffers
from small litter sizes. Furthermore, given that the cells used for
SCNT are typically clonal the resultant cohort of animals lacks
the heterogeneity of an outbred population; this can have
disadvantages when modeling a disease with heterogeneous
phenotype. As an alternative strategy, transgenic animals have
been produced with high efficiency using lentiviral vectors such
as the human immunodeficiency virus type 1 (HIV-1), simian
immunodeficiency virus (SIV) and equine infectious anemia
virus (EIAV) derived vectors [4–7]. This technology has been
effectively applied to many different species including, rats,
rabbits, pigs, chicken, sheep and non-human primates [8–12],
mostly to create green fluorescent protein (GFP) transgenic
animals and in few cases to model human disease. Lentiviral
transgenesis may be applied to generate animal models by
overexpression of a dominant negative mutant allele. This
method should give a broader picture of the disease state than
can be achieved by SCNT in that each individual in the cohort
will be genetically unique, both base genetics and expression
profile from multiple transgene insertion sites. This heterogene-
ity should thus permit modeling of the range of phenotypes
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observed in human patients affected by a disease and displaying
heterogeneity of penetrance or severity.
Retinal diseases displays such heterogeneity of penetrance and
severity, and while retinal function and morphology can be
easily evaluated in vivo allowing effective follow up in live
animals, there is a real need for retinal disease models for
biomedical research as the rodent retina poorly reproduces
human retina, especially regarding cone content. Rodents have
a retinal anatomy very different from humans. The mouse
neuroretina is composed mainly of rod photoreceptors, with
cones constituting only 3% of the total photoreceptor popula-
tion. The mouse retina is thus similar to the human peripheral
retina. Cones in human are concentrated in the macula (the
central region of the retina) and exclusively compose the fovea.
This central region is essential for sharp vision in conditions of
bright light, with the surrounding rod-enriched peripheral zone
providing greater sensitivity on lower light conditions. While the
mouse can provide a good model for diseases affecting the
peripheral retina or rods, its anatomy renders it inappropriate
for models of cone-dystrophies and macular degeneration [13].
Naturally occurring canine retinal models exist and these often
have advantages over murine transgenic models: more progres-
sive degeneration mimicking more closely the human pathology
and eye size closer to the humans’ allowing the efficiency of
therapies to be tested at an appropriate surgical scale. However,
the number of dog colonies established for preclinical research is
very limited. Indeed, such colonies mostly rely on fortuitous
discovery and require prolonged breeding strategies to generate
experimental cohorts. In addition, identified mutations may be
associated with additional disease phenotype, thus rendering
precise analysis difficult. As a consequence, dog models are
unpredictable and costly [14,15].
The pig is an appropriate alternative choice as an ophthalmol-
ogy model since it has an enriched cone region in the central part
of the retina making a transversal naso-temporal streak resembling
the primate macula. Moreover, as pig can be genetically
engineered with relative ease this species is an attractive alternative
for de novo model generation.
In the current study we investigated whether lentiviral
transgenesis could be applied to rapidly produce a heterogeneous
cohort of transgenic animals bearing different copy numbers of a
dominant-negative transgene inducing cone(-rod) dystrophy
(CORD). CORDs represent around 10–20% of all retinal
dystrophies and are genetically and phenotypically heterogeneous.
The loss of vision is progressive with first report of visual acuity
impairment in the first decade, followed by nyctalopia, decrease of
peripheral vision and loss of color vision. On the histological level,
structural alteration of outer-segments and reduction of the retina
thickness have been reported. Although genetic studies in humans
have associated several loci to CORD, how specific mutations
affect the cone cells is until now poorly understood in part due to
the lack of relevant models.
The GUCY2D gene codes for a guanylate cyclase, an
enzyme involved in the regulation of calcium influx in rods and
cones. Mutations in this gene, identified as the CORD6 locus,
show the most prevalent association with dominant transmission
of the CORD [16–18]. GUCY2D activity indirectly depends on
intracellular calcium levels via activation and binding of the
guanylate cyclase activating protein (GCAP). Recent reports
suggest that dominant mutations of GUCY2D increase the
stability of the protein which favors the binding of the GCAP
independently of its activation status [19]. The activation of the
GUCY2D mutant would thus be less sensitive to the
intracellular calcium level, and would lead to excess of
intracellular calcium in photoreceptors, as suggested by in vitro
studies [20,21]. The GUCY2D gene is expressed both in rods
and cones and the reason why this mutation primarily affects
cones is poorly understood. This question can hardly be
elucidated in rodent models, we thus generated transgenic pigs
expressing the double mutant GUCY2DE837D/R838S. Visual tests
and histological analyses performed on transgenic animals show
heterogeneous phenotypes with common alterations including
decreased cone function and disorganization of cones consistent
with clinical reports [18]. The CORD6 pig model generated in
this study thus represent a valuable animal model for
translational studies. Moreover, the transgenic methodology
can be applied to other diseases where heterogeneity of
phenotypes is sought.
Methods
Ethical Statement
The animals were handled in accordance with the statement of
the ‘‘Animals in Research Committee’’ of the Association for
Research in Vision and Ophthalmology and with appropriate
authorized and licencing under the Animal (Scientific Procedures)
Act 1986 in the UK. The work carried out in this study was given
approval by the Roslin Institute Animal Welfare and Ethics
Committee.
Comparative Promoter Analysis
The 2 kbp upstream plus 200 bp downstream genomic regions
flanking the respective bp one of the pig, human and mouse Arr3
reference mRNA (NM_214345, NM_004312 and NM_133205)
were extracted for the initial promoter analysis. These promoter
sequences were first aligned with Lastz (v1.03.02) [22], allowing 8
mismatches out of the 19 bp seed, and blocks of conserved regions
detected in 50 bp sliding windows were visualized with zPicture
[23] (Fig. 1C). Transcription factor binding sites falling on these
regions were scanned using the MATCH algorithm included in
TRANSFAC 7.0 [24] while those on the core promoter regions
were searched against the JASPAR’s POLII sub-database (http://
jaspar.genereg.net/). Refined alignment (Fig. 1D) of the core
promoter region of the 3 sequences was done using the program
MUSCLE (v3.8.31) [25].
Transgenesis and Genotyping
Transgenic pigs were generated and genotyped as described
previously [7]. Briefly, zygotes were collected by flushing the
oviducts of artificially-inseminated super-ovulated Large-White
gilts. 50 or 500 pl lentivirus suspension (148 ng p24/mL) was
injected into the perivitelline space, following which 30 zygotes
were transferred to the oviduct of identically treated but unmated
recipients. Genomic DNA was prepared from ear biopsies, and
initially assessed for presence of lentivirus-vector transgene
integrants by PCR with primers HIV1 (GAGAGA-
GATGGGTGCGAGAG) and HIV2
(GCTGTGCGGTGGTCTTACTT) which span the lentiviral
packaging signal sequence, and the transgene copy-number
subsequently determined by Southern blot.
RT-PCR
Retina RNA extraction was performed in Trizol (Life Tech-
nologies) according to manufacturer instructions and following
physical disruption. Total RNA were purified using RNeasy Mini
Kit (Qiagen). Reverse transcription was performed using SUPER-
SCRIPT 3 1st STRAND (Invitrogen) and oligo dT. cDNAs were
then amplified with specific primers: pig glyceraldehyde-3-
Transgenic Pigs for Dominant GUCY2D Mutant
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e71363
Figure 1. Strategy for the GUCY2DE837D/R838S transgenesis. (A) Comparative analysis of the cone arrestin promoters from human, pig and
mouse was performed. The 2 kbp upstream plus 200 bp downstream human and pig Arr3 promoters were aligned against that of the pig. Brown
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phosphate dehydrogenase (GAPDH) cDNA (GATGGT-
GAAGGTCGGAGTGA and AGGCATTGCTGAC-
GATCTTG), pig GUCY2D cDNA (GAGGACCTGATCGGG-
GAGC and CACCTTGTAGACATCATGGGAG), human
mutant GUCY2D cDNA (GAGGATCTGATCCGGGACA and
TCTCCACCTTGTAGACATCG).
Full-field Electroretinogram (ERG)
Animals were sedated with ketamine (10 mg/kg, intramuscular
injection, Vetalar V, Pfizer Ltd) and azaperone (2 mg/kg,
intramuscular injection, Stresnil, Elanco Animal Health) and
maintained anesthetized under oxygen, by intravenous injection of
a mix of ketamine (2 mg/kg) and midazolam (0.2 mg/kg,
Hypnovel, Roche Products Ltd). Pupils were dilated by topical
administration Tropicamide 0.5% (Mydriacyl Eye Drops, Alcon),
and phenylephrine 10% (phenylephrine hydrochloride eye drops,
Bausch and Lomb). Unilateral recording was performed using
DTL electrodes and the RETI-com portable device (Roland
Consult, Brandenburg an der Havel). After 5 to 10 minutes
opened eyelids under room light, a photopic protocol described by
International Society for Clinical Electrophysiology of Vision
(ISCEV) [26] was used to measure single flash and 30 Hz flicker at
3 cds/m2 and a supplementary single flash at 10 cds/m2 and
10 Hz flicker at 3 cds/m2. The response was established by
averaging 8 flashes of 5 s interval for the 3 cds/m2 stimuli and 4
flashes of 5 s interval for the 10 cds/m2 stimuli and 8 flashes for
flickers.
Behavioural Test
At 11 weeks of age a maze was constructed with 2 panels where
a passage was opened in order to let the animals go through it to
reach a color object (yellow and blue) laying at the end. The
luminance varied from 500 to 800 lux through the maze. The
animals were recorded and the time to reach the object was
quantified.
At 24 and 52 weeks, obstacle courses were arranged in corridors
of 1.32 and 2.38 m wide and 10 and 13 m long respectively. Red
construction cones (47 and 77 cm of height respectively) were used
as main obstacles. Additional obstacles were used for the 24 weeks
test: some buckets (27 to 33 cm of diameter and 21 to 25 cm of
height) and a Frisbee hanged up at 47 cm high. The luminance
varied from 1000 to 2000 lux for the 24 week test and from 800 to
1300 lux for the 52 week test, all above 500 lux to ensure minimal
rod input. The animals were recorded during their progression
through the obstacles and then the videos analyzed to determine
the time for reaching the end of the course, the number of errors
(unintentional contact with an obstacle as evidenced by a startle
response to the contact) and the number of objects that were
approached by other senses than vision like sniffing or licking, a
behavior we called ‘‘alternative prospection’’ which would suggest
that vision is not sufficient for them to appraise their environment.
We also determined a score as the sum of errors or alternative
prospection for each pig.
In vivo Imaging
Retinal morphology in the region spanning 1.5 to 4 mm dorsal
to the optic nerve was assessed under anesthesia using the spectral
domain optical coherence tomography (SDOCT) from Bioptigen
(Durham).
Histology-Immunohistology
Collected eyes were superficially cauterized, incubated over-
night (4uC) in 4% paraformaldehyde and stored in PBS until
processing. The eye were orientated and cut vertically in half: the
nasal hemisphere was equilibrated in PBS with 30% sucrose before
embedding in home-made mounting medium (albumin from hen
egg white (Fluka) mixed with gelatin) for cryosection. The
temporal hemisphere was paraffin-embedded. Cryosections of
16 mm and microtome paraffin sections of 6 mm were collected on
superfrost plus slides (Menzel-Gla¨zer) and stored at 220uC.
For immunohistological analysis on cryosections, slides were
rehydrated and blocked for 1 hour at room temperature in PBS
with 10% normal goat serum (Dako) or donkey serum (Milan
Analytica AG) and 0.2% Triton-X 100. Peanut agglutinin lectin
(lectin from arachis hypogaea, PNA) labeling was performed using
PNA-TRITC (1:4000, Sigma). Primary antibodies: medium
wavelength opsin (M-opsin) rabbit antibody (1:1000, Chemicon),
short wavelength opsin (S-opsin) goat antibody (1:1000, Santa
Cruz), glial fibrillary acidic protein (GFAP) rabbit antibody (1:400,
Dako). Secondary antibodies (1:2000, Alexa FLuor488 goat
anti-rabbit IgG or Alexa Fluor488 donkey anti-goat IgG,
Invitrogen). DAPI (49,69-diamidino-2-phenylindole, Molecular
Probes inc) counterstaining was performed and the sections were
mounted with Mowiol 4–88 (VWR). Paraffin sections were
stained with the standard hematoxylin-eosin (HE) staining.
IHC Quantification
Central sections along the naso-temporal axis were used for
quantification. Displaced nuclei were determined in the full section
stained by hematoxylin-eosin. Counting of PNA or M-opsin
outersegments was performed across a 100 to 300 mm length of
the retina, 1.6 mm superior to the optic nerve, in the visual streak
as described by Hendrickson et al. [27].
Statistical Analysis
Statistical analyses of the electroretinograms and histological
data were performed by two way-ANOVA and post-tests
determined the statistical significance between the different groups
(transgenic and non-transgenic).
Results
Strategy to Engineer a Cone Dystrophic Model in Pig
Modelling cone dystrophy in a large animal is of prime
importance to understand cone pathophysiology and to test new
treatments in a physiologically relevant context. Among large
animal species, swine is particularly relevant to study cones
because of its similarity in size and metabolism to human and
Conserved blocks with similarity higher than 70% were colored red under the curve. (B) The core promoter region was found to be highly conserved
in pig, human and mouse. Four potential binding sites for the CRX photoreceptor transcription factor could be identified while the conserved TATA-
boxes are located about 230 bp upstream of the published transcriptional start sites (TSS) [33,60]. TSS of the pig Arr3 gene was predicted by
comparing the sequence with the JASPAR’s initiator weight matrix. Other promoter elements, such as CAAT-box, SP1, TATA-box associated with
minor TSS, were not shown. (C) Schematic of the transgene cassette encoding the human mutant GUCY2DE837D/R838S cDNA under the control of a
fragment of the pig cone arrestin promoter. LTR: Long terminal repeat, the 39 LTR is designated as ‘‘delta U3’’ for a fragment of the U3 region has
been deleted, rendering the vector ‘‘self-inactivating’’, i.e. unable to replicate once in the target cell, this also prevents interference of the HIV
promoter with the internal Arr3 promoter; cPPT-CTS: central polypurine tract – Central termination site.
doi:10.1371/journal.pone.0071363.g001
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because it has an enriched region for cones in its retina.
Additionally, pig transgenesis is efficiently performed using a
lentiviral vector as we previously showed [7], reaching efficiency
rates typically between 20 to 100 per cent. Lentiviral transgenesis
can be used to specifically express a dominant mutant allele,
thereby inducing pathology in the transgenic animals. Moreover,
as each transgenic animal of the F0 generation (founder
population) is unique, being derived from individually transduced
zygotes, we should obtain a cohort of transgenic animals with
different transgene copy numbers and genome integration sites
which will result in a range of transgene expression profiles and
thus a range of pathology severity. The overall strategy is thus to
construct a lentiviral vector for expression of a dominant mutated
cDNA driven by a cone-specific promoter and to use this vector to
generate a heterogeneous cohort of transgenic pigs and finally to
assess the pathological features of the candidate mutation.
Some mutations of the GUCY2D gene are identified as a major
cause of autosomal dominant inherited cone degeneration in
humans [28], such as CORD6 dystrophy where cones and
subsequently rods are affected. The GUCY2DE837D/R838S double
mutant allele was used in this study because this mutant is linked to
a more severe phenotype than single mutants. In order to generate
animals with potential cone degeneration, we designed a vector
where transcription of the mutant allele is controlled by a fragment
of a cone specific promoter. The cone arrestin-3 promoter
demonstrated cone-specific expression in Xenopus and mouse
[29–31]. In addition, a transcriptomic study of 35 different pig
tissues found the arrestin-3 gene to be expressed only in the retina
[32]. To further ensure this specific regulation in pig, we aligned
the 2.2 kbp human and mouse cone arrestin promoter region
against that of the pig.
The pig Arr3 promoter shares significant conserved regions with
that of human and mouse in the 21.2 kbp and the core promoter
regions (Figure 1A). Cis-elements essential for transcription
initiation, such as TATA-box and Inr, and the binding sites for
the photoreceptor transcription factor CRX are conserved in all
three promoters (Figure 1B). To avoid the potential negative
regulation on the promoter activity observed by Zhu et al. [33], a
search for repressor binding sites was carried out on the three
promoters. A conserved binding site for the CCAAT-box
displacement repressor protein was identified at about 760 bp
upstream of the pig transcription start site. We thus selected a
724 bp pig arrestin-3 promoter made up of a sequence from 2687
to +36 bp of transcription start site. The designed pig arrestin-3
promoter was inserted into a lentiviral vector backbone upstream
of the cDNA of the human GUCY2D gene containing 2
substitutions 837 E-.D and 838 R-.S (Figure 1C).
Efficient Lentiviral GUCY2DE837D/R838S Transgenesis in Pig
Using the transgene cassette described above, lentiviral vectors
were produced and transgenic pigs were generated as described
previously [7]. From two recipient animals, 22 piglets were born,
of which 13 were confirmed as transgenic by Southern blot
(Table 1) representing a 60% transgenesis efficiency. Seven non-
transgenic piglets were examined in this study as controls. On a
gross level transgenic offspring were indistinguishable from
controls both physiologically and behaviourally. Animals were
co-housed and cared for using standard husbandry practice. To
assess for transgene expression, we performed RT-PCR on RNA
extracts from the retina of the right eyes of 8 transgenic pigs
sacrificed at 78 weeks. The GUCY2DE837D/R838S transcript was
found in all transgenic pigs (904, 907, 908, 914, 915, 917, 918,
920) but not in control animal (929) while PCR for the endogenous
pig GUCY2D mRNA detected transcript in both transgenic and
control animals (929) (Table 1, Figure 2). These results taken
together confirm the efficiency of lentiviral-mediated transgenesis
Figure 2. Expression of GUCY2DE837D/R838S transcript in transgenic pigs. Assessment of transgene expression by RT-PCR. Transgenic pigs:
904, 907, 908, 914, 915, 917, 918, 920, control non-transgenic pig (929). +: with reverse transcription; 2: without reverse transcription; hGUCY2Dmut:
GUCY2DE837D/R838S PCR fragment; pig GUCY2D: pig GUCY2D PCR fragment; GAPDH: pig GAPDH PCR fragment.
doi:10.1371/journal.pone.0071363.g002
Table 1. Identification of the number of copy and the retinal
expression of the transgene in GUCY2DE837D/R838S transgenic
pigs.
sow ID piglet ID copy No. sex RT-PCR
4023 902 3 m nd
904 1 m +
906 1 m +
907 5 m +
908 2 m +
909 3 f nd
4020 913 5 m nd
914 2 m +
915 2 m +
917 3 m +
918 3 m +
919 6 m nd
920 4 m +
ID: identification of the animal; No: number; RT-PCR; amplification of
GUCY2DE837D/R838S transcript; m: male; f: female; +: amplification of the
fragment of GUCY2DE837D/R838S transcript; 2: no amplification of the fragment
of GUCY2DE837D/R838S transcript; nd: not determined.
doi:10.1371/journal.pone.0071363.t001
Transgenic Pigs for Dominant GUCY2D Mutant
PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e71363
to generate pigs expressing the human GUCY2DE837D/R838S allele
in their retina.
Impairment of Retinal Function in GUCY2DE837D/R838S
Transgenic Pigs: Electrophysiological Assessment
In order to determine whether the expression of the dominant
negative mutant GUCY2DE837D/R838S induces a phenotype, the
GUCY2DE837D/R838S transgenic pigs were first characterized by
functional analysis of the retina. The retina activity under photopic
(well lit) conditions, which originates mainly from the cones, was
measured by electroretinogram (ERG) recording at 11 and 52
weeks of age, with a protocol used for human examination [26]. A
reduction of the amplitude was observed in transgenic group,
although the kinetics of the response was well preserved compared
to control animals. This decrease was observed for both single
flash and flicker stimuli, the latter revealing more specifically cone
activity (Figure 3A, third column) and this phenotype was
observed at both ages assessed (Figure 3B, 3C). Despite
heterogeneity, the difference of amplitude between transgenic
and control groups was statistically significant at 11 weeks, at both
single flash intensities for the b-wave but only at higher intensity
for the a-wave (p = 0.04, Figure 3B,C). Decreased a-wave reveals
partial loss of photoreceptor activity, whereas the b-wave,
generated by interneurons processing the output of photorecep-
tors, is more severely affected as it represents a signal amplifica-
tion. ERG results thus highlight that GUCY2DE837D/R838S
overexpression negatively impacted on cone activity, with early
onset in most animals and high variability among transgenic
individuals.
Measurement of retinal response at 52 weeks revealed increased
variation in both the control and transgenic groups with an
average response lower than recorded at 11 weeks (mean b-wave
amplitude 6 SEM for controls: 235 mV 640 (n= 6) at 11 weeks vs
158 mV 638 (n= 6) at 52 weeks). Seven out of the 10 transgenic
pigs examined had a b-wave amplitude lower than the mean of
control animals, although results were not statistically significant.
ERG analysis at this latter time point thus reveals that the
alteration of the ERG response is maintained and the variability is
further increased compared to analysis at 11 weeks.
Impairment of Retinal Function in GUCY2DE837D/R838S
Transgenic Pigs: Behavioral Assessment
Electroretinogram recording objectively measures the global
retinal activity and can be affected before the individual effectively
reports visual impairment [34]. The useful vision of the animals
was thus further evaluated with behavioural tests. These tests were
performed at 11, 24 and 52 weeks of age and, as for ERG
measurement, they were conducted under photopic conditions to
minimise the input of rods. Desensitization of the rod system has
been previously characterized in mice: a light intensity as low as
150 lux is sufficient to reduce rod activity to 50% of their maximal
response, and rod activity is further reduced to 30% of the peak
response under 1750 lux illumination [35]. In contrast to mouse,
humans have a retina adapted to day activity and, as a
consequence, although the saturation of human rods is still
debated, the highest luminance proposed is much lower than in
mouse; between 10 and 100 lux [36]. These parameters have not
been evaluated in pig retina. However, because its composition
and organisation are also adapted to a diurnal activity mainly
using cones, we hypothesized that a light intensity above 500 lux
should not allow much rod input in the general visual function.
Thus visual behaviour was evaluated between 500 and 2000 lux at
the 11, 24 and 52 weeks of age. To accommodate the size
differences of the animals between tests (approximately 40 kg at 11
weeks vs approximately 180 kg at 52 weeks) and to minimise
association, the design of the test was modified between the three
time points. For this reason, results should be considered
independently, providing comparison between groups within each
time point and not between time points. Pictures of the 3 tests set
up are presented on Figure S1. Examples of animals navigating
through the obstacle course are presented in Movie S1.
Mobility at 11 weeks was evaluated by (1) measuring the time
for the pig to pass through doors to reach an object, and (2)
determining whether the animal bumped into the doors. At 24 and
52 weeks we quantified the success of the obstacle course based on
3 criteria: (1) the time to complete the course, (2) the number of
obstacles that the animal touched (‘‘errors’’) and (3) the number of
obstacles that the animal explored using other senses than vision
like smelling or licking (‘‘alternative prospections’’). Combination
of these 2 last criteria determined a global score.
The first test at 11 weeks of age didn’t reveal any severe visual
handicap with no significant difference between transgenic and
control groups on the number of errors or time to accomplish the
task (non-transgenic mean time (n= 5) 5.4 s 61.3; transgenic
mean time (n = 13) 5.761). The absence of severe visual
impairment and the decreased ERGs measured at the same time
point suggest an early stage of the disease.
Differences between transgenic and control animals became
apparent at 24 and 52 weeks. While the performances of the
control animals are homogeneous (control mean time 6 SEM at
24 weeks (n = 6) 14.3 s 63.2, at 52 weeks (n = 6) 12.5 s 61; mean
score 6 SEM at 24 weeks 160.5, at 52 weeks 0.560.2), the scores
of the transgenic animals are increased and more widely scattered
(transgenic mean time 6 SEM at 24 weeks (n = 12) 32.2 s64.6, at
52 weeks (n = 10) 24 s 65.6; mean score 6 SEM at 24 weeks
3.360.7, at 52 weeks 2.260.4; Figure 3D,E). The visual
impairment is not obviously detected through the ‘‘error’’ criteria:
only 3 transgenic animals out of 12 animals analyzed at 24 weeks
missed obstacles. Interestingly, the ‘‘alternative prospection’’
criteria revealed a particular behaviour: most of the transgenic
pigs (10 out of 12 at 24 weeks and 10 out of 11 at 52 weeks) smelt
or licked some obstacles before continuing the obstacle course
(Figure 3E). This particular behaviour is generally associated with
prolonged time to complete the obstacle course but does not
correlate with the error frequency: the two transgenic pigs that
approached the obstacles more often for the purpose of smelling or
licking did not do any errors. Taken together, the results of these
behavioural evaluations are consistent with transgenic animals
displaying symptoms of visual impairment which they may
compensate using other senses.
Morphological Alterations of Cones in GUCY2DE837D/R838S
Transgenic Pigs
To verify whether the alteration of visual function observed was
associated with retinal morphology changes, in vivo imaging was
performed on anesthetized pigs by spectral domain optical
coherence tomography (SDOCT) at 24 and 52 weeks of age.
This examination did not reveal severe modifications of the retinal
morphology of transgenic pigs when compared to control animals
(Figure S2). Pigs were sacrificed at different time points (18, 70 and
83 weeks) to enable further histological analysis of the retina.
Consistently with SDOCT images, we didn’t notice any major loss
of structure at the gross morphological level (Figure 4A,B). Some
transgenic animals however appeared to have significant retinal
modifications when analysed at a cellular scale, including an
alteration of the compact cellular organisation characteristic of the
photoreceptor outer nuclear layer (ONL) and the interneuron
Transgenic Pigs for Dominant GUCY2D Mutant
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Figure 3. Range of visual function in GUCY2DE837D/R838S transgenic pigs. (A) Traces of photopic electroretinogram recordings (ERG) at 11
weeks are shown for one representative control and several transgenic animals. (A, first column) single flash at 3 cds/m2, (A, second column) single
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inner nuclear layer (INL) (Figure 4A,B). We also observed Mu¨ller
cell activation, revealed though GFAP immunoreactivity in the
ONL which may explain the slight loss of ONL compaction
(Figure 5H). This gliosis phenomenon is a typical feature of
diseased retina and was not observed in control animals (Figure 5L,
Figure 6N). More interestingly, in all transgenic animals, even at
the earliest time point analysed (18 weeks), displaced nuclei were
observed in the outer segment (OS) layer, (Figure 4A,B). While
such displaced nuclei could be detected in both transgenic and
control animals, they were significantly increased in the transgenic
group for all the ages investigated (p,0.01, Figure 4C). Most of
these ectopic nuclei colocalised with cone markers: components of
the cone extracellular matrix (recognised by PNA) and cone
photopigments (M-opsin or S-opsin) (Figure 4D–F; Figure 5E–G,
Figure 6E–G,I,J). Further quantification of M-opsin and PNA
positive cells revealed decreased expression of these proteins in the
OS of some transgenic animals (Figure 4I), suggesting an alteration
of cone health. This decrease was correlated to a diminution of
cone OS number determined by morphological observation of
paraffin sections (pigs 907, 917, 918 mean 6SEM: 1461 OS/
100 mm, control group mean 6SEM: 1861 OS/100 mm, n= 3,
p=0.02). Results of histological analysis thus reveal subtle signs of
retinal alteration in the transgenic group.
Variability of the Phenotype of GUCY2DE837D/R838S
Transgenic Pigs: Case Report
Taken together, the results of characterization of the transgenic
animals reveal retinal alteration of the transgenic animals when
compared to controls. Of note, an important phenotypic
heterogeneity is observed among the transgenic group that likely
reflects the heterogeneity inherent to the generation of outbred
transgenic animals associated with random insertion of a
promoter-transgene cassette. In essence each animal in the
transgenic cohort is unique as a consequence of its genetic
background, the variation in the natural level of its endogenous
GUCY2D gene associated with variable expression of the
transgene, whereby both copy number and position effect can
influence expression levels. We selected particular transgenic pigs
that are described hereafter in a case report manner to further
illustrate this diversity: pigs 908, 920 and 917, respectively
genotyped with 2, 4 and 3 integrated copies of the vectors;
transgene expression was confirmed in each one post mortem (83
weeks, Figure 7D, 5D, 6D).
Two animals were particularly poorly affected during the course
of the experimentations. As an illustration, results of pig 908
phenotyping are recapitulated in Figure 7. This animal maintained
relatively normal features, except an increase in the number of
displaced nuclei (Figure 7C). Longer follow up of this animal
would have been required to determine whether it was developing
a milder or delayed form of the disease. This clearly contrasts with
several other transgenic animals that displayed both earlier onset
and more significant progression throughout the course of the
reported observations.
Pig 920 maintained normal retinal function up to 52 weeks
regarding ERG recordings but progressed slower through the
obstacle course and with more difficulties than non-transgenic
animals (Figure 5A–B). On the histological level, at 83 weeks of
age, despite normal cone labelling (PNA, M-opsin markers)
(Figure 5E–G), we observed increased displaced nuclei
(Figure 5C) and GFAP staining in the ONL (Figure 5H,L)
revealing Mu¨ller cell activation and retinal damage. Thus, retinal
expression of the transgene GUCY2DE837D/R838S correlates with
abnormal retinal morphology and progression through obstacles
but didn’t lead to a severe phenotype by 52 weeks of age.
Pig 917 showed a more pronounced phenotype with retinal
activity being severely reduced by 11 weeks of age (Figure 6B).
This phenotype was maintained throughout the experiment and
no further decrease of the ERG response was observed at 52 weeks
(Figure 6A). Behavioural observations suggest that useful vision
was affected, with this animal taking more time to finish the
obstacle course and conducting many more alternative prospec-
tions than did controls (Figure 6B). In parallel, an increased
number of displaced nuclei and a reduced number of PNA- or M-
opsin-labeled cones were observed at 83 weeks of age (Figure 6C,E-
G). Increased GFAP staining was also noticed in the ONL,
although less pronounced than in pig 920 (Figure 6H). Thus,
expression of the GUCY2DE837D/R838S transgene in pig 917 is
associated with reduced ERG response, reduced visual acuity and
altered retinal morphology.
Discussion
GUCY2DE837D/R838S Transgenic Pigs as a Relevant Model
to Study Cone Dystrophies
A transgenic pig line generated through SCNT has previously
been used to study rod diseases [37]. Our study further shows that
cone diseases can be investigated and monitored in the pig retina
by functional and histological analysis. Until now, animal models
to study cone biology were poor. Genetic studies in humans have
established a strong correlation between a severe cone–rod
dystrophy and the GUCY2DE837D/R838S mutations suggesting
that this mutation affects cone metabolism [17–19,38]. Recently,
Collery et al. [39] described a zebrafish model, generated using the
same CORD6 double mutation described above (GUCY2DE837D/
R838S). The animals displayed altered retinal structure with
reduction of the number of photoreceptor nuclei as well as
reduction of some specific photoreceptor markers. Retinal
modifications were observed as early as at the larvae stage but
the progressive nature of the symptoms was not easily appreciated,
probably because of the retinal regenerating capacity in these
animals. Surprisingly, these structural defects were not associated
with alteration of the visual function, as measured by optokinetic
response. In contrast, the GUCY2DE837D/R838S transgenic pigs we
describe displayed a modified behavioral phenotype, a reduced
retinal function as measured by ERGs and histological evidences
of retinal alterations, features that are closer to the human disease
than the zebrafish model.
ERG, recorded using the human protocol (ISCEV), revealed
significant differences between transgenic and non-transgenic
animals as early as 11 weeks. Simple visual behavioral tests
applied to assess the useful vision of the pigs revealed clear changes
flash at 10 cds/m2, (A, third column) flickers at 3 cds/m2,30 Hz. (B) b-wave amplitudes for all examined animals at 11 weeks with single flash at 3 cds/
m2 and at 10 cds/m2. (C) a-wave amplitudes obtained for all examined animals at 11 weeks with single flash at 3 cds/m2 and at 10 cds/m2. (D)
Representation of the time needed to complete the obstacle course at 24 and 52 weeks for transgenic and non-transgenic control animals. (E)
Representation of the errors (missing or striking into an obstacle), alternative prospections (the number of times individuals investigated an obstacle
by sniffing or licking) and resulting scores from the obstacle course at 24 and 52 weeks for transgenic and non-transgenic control animals. Horizontal
bars in B,C represent the mean of the different groups with the SEM; *: p,0.05;***: p,0.001; errors in E: miss or strike into an obstacles; alternative
prospection in E: sniff or lick the obstacles; score in E: sum of errors and alternative prospections.
doi:10.1371/journal.pone.0071363.g003
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between the most affected animals and the controls and evidenced
visual impairment leading to reduced vision in transgenic pigs at
24 and 52 weeks. The test built for 11 weeks animals was probably
not stringent enough to discriminate mild vision impairments, but
Figure 4. Abnormal retinal morphology in transgenic pigs. (A) Morphological examination of a retina from a control animal reveals retinal
layers: outer segments (OS), inner segment of photoreceptors (IS), photoreceptor nuclei (ONL). (B) Displaced nuclei were observed in the outer
segment layer in transgenic retina (arrows). (C) Quantification of the number of displaced nuclei in transgenic and control animals. (D,E,F)
Immunolabeling for specific cone markers PNA and M-opsin in transgenic retina identified most of these displaced cells as cones. (G,H)
Immunolabeling for specific cone markers PNA and M-opsin in control retina. (I) Quantitation of relative density of displaced cones as determined by
PNA or M-opsin labeling across 100 mm on the section. OS: outer segment; IS: inner segment; ONL: outernuclear layer; PNA: peanut agglutinin; M-
opsin: medium wavelength opsin; nb: number. Scale bar in A, B and D to F represents 50 mm.
doi:10.1371/journal.pone.0071363.g004
Figure 5. Case reports: pig 920. Grouped data collected for the transgenic pig 920 (4 integrated copies). (A) Photopic ERG (single flash 3 and
10 cds/m2 and 30 Hz flicker) at 11 and 52 weeks. (B) Behavioural observation for pig 920 (red opened circle) compared to non-transgenic control
animals (black lozenges, mean and SEM depicted). (C) Histological quantification compared to the mean 6 SEM of the non-transgenic controls. (D)
RT-PCR analysis of transgene, endogenous GUCY2D and GAPDH gene expression in the retina. (E–L) Immunolabeling for M-opsin (E,I), PNA (F,J) and
merged picture (G,K), and GFAP (H,I) in the central region of the retina of pig 920 (E–H) and a non-transgenic control (I–L). Arrows in E, G, I and K show
examples of M-opsin positive outersegment, arrowhead in G shows a displaced nucleus. W: weeks of age; OS: outer segment; ONL: outer nuclear layer
(photoreceptor nuclei); INL: inner nuclear layer (interneuron nuclei); IS: inner segment; M-opsin: M-opsin antibody in green; PNA: peanut agglutinin in
red; DAPI: dapi counterstaining in blue; GFAP: Glial fibrillary acidic protein in green; S-opsin: short wavelength opsin in green. Scale bar in E–L
represents 50 mm.
doi:10.1371/journal.pone.0071363.g005
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it suggests that no dramatic visual impairment occurs at this early
age. Indeed, in the first visual test settings, the distance to cover
was short and doors to cross might have been too easy to detect.
The correlation between low ERG and impaired vision-conducted
behavior is not obvious. Some animals with low ERG have low
vision while others navigate well through the obstacles. Converse-
ly, animals with nearly normal ERG exhibit impaired navigation
capacity. One may hypothesize that animals with slow disease
progression could display a degree of adaptation, whereby they
learned to cope with reduced visual acuity over time. Alternatively,
it may be that degeneration within the cone-enriched horizontal
streak is not homogeneous, resulting in regions of impaired vision
rather than a more general diminution of visual acuity – in this
scenario specific visual impairment would not necessarily correlate
directly with gross ERG reduction because partial loss can be
masked in the global response recorded by ERG.
Similarly, progressive visual impairment is commonly observed
in patients affected by cone dystrophies, such as CORD6, with
disease onset spanning the first decade [18,38,40,41]. This
decrease of the visual acuity is the first symptom occurring in
patients followed by impairment in color discrimination in a later
phase of the disease. Recent studies report learning ability of pigs
[42–46] allowing in the future the investigation of such phenotypes
in pig through more complex behavioral tests. Retinal structure
was assessed by in vivo imaging (SDOCT) and post-mortem histology.
The only available description of CORD6 patient’s retina is the
report of Kim et al. [40] describing the use of SDOCT to visualize
photoreceptor abnormalities in a 13-year old patient bearing a
GUCY2DR838H mutation. This child had experienced progressive
loss of vision in both eyes over the preceding 3 years, with reduced
ERG. OCT examination revealed several abnormalities of the
retina, including thinning at the fovea of each eye as well as
thinning of the RPE in the central retina and structural alteration
Figure 6. Case reports: pig 917. Grouped data for the transgenic pig 917 (3 integrated copies). (A) Photopic ERG (single flash 3 and 10 cds/m2 and
30 Hz flicker) at 11 and 52 weeks. (B) Behavioural observation for pig 917 (red opened circle) compared to non-transgenic control animals (black
lozenges, mean and SEM depicted). (C) Histological quantification compared to the mean 6 SEM of the non-transgenic controls. (D) RT-PCR analysis
of transgene, endogenous GUCY2D and GAPDH gene expression in the retina. (E–P) Immunolabeling for M-opsin (E,I), PNA (F,J) and merged picture
(G,K), GFAP (H,I) and S-opsin (I,J,O,P) in the central region of the retina of pig 917 (E–J) and a non-transgenic control (K–P). Arrows in E, G, K and M
show examples of M-opsin positive outersegment, arrowhead in G shows displaced nuclei, arrowhead in J shows a displaced nucleus in a S-opsin
positive cell. W: weeks of age; OS: outer segment; ONL: outer nuclear layer (photoreceptor nuclei); INL: inner nuclear layer (interneuron nuclei); IS:
inner segment; M-opsin: M-opsin antibody in green; PNA: peanut agglutinin in red; DAPI: dapi counterstaining in blue; GFAP: Glial fibrillary acidic
protein in green; S-opsin: short wavelength opsin in green. Scale bar in E–J represents 50 mm.
doi:10.1371/journal.pone.0071363.g006
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of outer-segments. Although such alterations were not observed in
the transgenic animals through either OCT or histology, we report
remodeling consistent with retinal stress: decreased number of the
PNA- and M-opsin positive cone cells, decreased number of cone
outer-segments, increased gliosis and increased number of cone
nuclei displaced in the outer-segment layer. Ectopic nuclei are a
hallmark of certain cone dystrophies, as shown in the XLPRA
dogs bearing mutations in the RPGR photoreceptor ciliary protein
[47] as well as in the model of slow progressive retinopathy in
Shetland sheepdogs [48]. This result suggests that the GU-
CY2DE837D/R838S transgenic pigs show early signs of the
degeneration process, which has not previously been described
in patients.
Taken altogether, our results show that the features of the
cohort of GUCY2DE837D/R838S transgenic pigs recapitulate well
the features of CORD6 human patients [49–51]. Further
characterization of this model will contribute to a better
understanding of the physiopathology of CORD, thereby supple-
menting ongoing investigations in human patients. Most interest-
ingly, the increased presence of displaced nuclei in the segment
layers appears to be a common feature of cone dystrophy and
could be an early marker of the disease.
Pig Lentiviral Transgenesis to Model Diseases with
Phenotypic Heterogeneity
Beyond the ophthalmology field, pigs have many anatomical
and physiological similarities to humans, including their cardio-
vascular system, omnivorous gastrointestinal tracts and immune
system. They are thus recognized as excellent models for a variety
of diseases and are appropriate for development of new surgical,
endoscopic and delivery techniques. Together with the recent
advances in the fields of genetic modification of large species, pig is
particularly suited for developing new transgenic animal models.
The present study shows that lentiviral transgenesis in pig allows
the easy and rapid generation of a large number of transgenic
founder animals expressing a dominant-negative allele, without
the need to establish a colony. Because gilts may deliver 8 to 14
piglets with a gestation time of only 16 weeks, investigators may
envisage generating as many founders as needed for their
preclinical investigations in a relatively short period of time. For
instance, in this study, only two gilts were necessary to generate 13
transgenic animals and their non-transgenic littermate controls.
In addition to efficiency, another advantage of the approach we
used in this study is the heterogeneity it generates. Indeed, altered
retinal morphology coupled with reduced function are observed
among GUCY2DE837D/R838S animals with a spectrum of severity
that mimics the heterogeneity observed in patients, allowing to
Figure 7. Case report: pig 908. Grouped data for the transgenic pig 908 (2 integrated copies). (A) Photopic ERG (single flash 3 and 10 cds/m2 and
30 Hz flicker) at 11 and 52 weeks. (B) Behavioural observation for pig 908 (red opened circle) compared to non-transgenic control animals (black
lozenges, mean and SEM depicted). For technical reasons, the time to reach the end of the obstacle course has not been measured at 52 weeks. (C)
Histological quantification compared to the mean6 SEM of the non-transgenic controls. (D) RT-PCR analysis of transgene, endogenous GUCY2D and
GAPDH gene expression in the retina. (E–G) Immunolabeling for M-opsin (E), PNA (F) and merged picture (G) in the central region of the retina of pig
908. Arrows in E and G show examples of M-opsin positive outersegment, arrowhead in G shows a displaced nucleus. W: weeks of age; OS: outer
segment; ONL: outer nuclear layer (photoreceptor nuclei); INL: inner nuclear layer (interneuron nuclei); IS: inner segment; M-opsin: M-opsin antibody
in green; PNA: peanut agglutinin in red; DAPI: dapi counterstaining in blue; GFAP: Glial fibrillary acidic protein in green; S-opsin: short wavelength
opsin in green. Scale bar in E–G represents 50 mm.
doi:10.1371/journal.pone.0071363.g007
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perform individual case studies in the transgenic animals. This
diversity is likely due to a combination of transgene expression
level as a function of copy number and integration site, coupled
with the variable genetic background of the cohort (outbred
siblings and half-siblings). This is one of the strengths of this
approach as such variety is reminiscent of the variability generated
by a specific mutation type in different human patients, showing
incomplete penetrance or variability of symptom severity. This
phenomenon has been described for many human conditions,
including CORD6 patients which are differently affected, either
regarding the kinetics or the severity of the symptoms [18,38,41].
This has also been described in animal models through the
comparison of inbred strains of mice [52–59]. Although inbred
strains have been invaluable tools for deciphering many funda-
mental mechanisms, understanding human conditions and devel-
oping efficient and safe treatment should take into account natural
heterogeneity. In the context of our study, it enabled to point out
the increased presence of displaced nuclei and gliosis as common
feature of the disease. Thus, the diversity of phenotypes generated
by our approach facilitate the identification of the common
deleterious effects associated with the studied mutation and may as
well contribute to the identification of cofactors that positively or
negatively impact on the pathological process. Although intro-
ducing heterogeneity in preclinical investigations might be seen at
first sight as increasing the scattering of the results and hampering
their interpretation, heterogeneity may be sought in order to better
understand the human pathology, as illustrated in the present
study.
Supporting Information
Figure S1 Obstacle courses. (A) Photograph of the maze
used when pigs were 11 weeks of age. (B) Photograph of obstacle
course used to assess animals at 24 weeks of age. (C) Photograph of
obstacle course used to assess animals at 52 weeks of age.
(TIF)
Figure S2 Example of in vivo imaging of pigs. OCT
Scans of the central region of a non-transgenic control (A) and two
examples of transgenic animals (B,C) at 24 weeks show the
presence of both photoreceptor nuclei (ONL) and outer segments
(OS). Vertical bar indicate the thickness of layers representative of
the outer nuclear layer (ONL) or outer segments (OS).
(TIF)
Movie S1 Examples of a control pig and a transgenic pig
navigating through the obstacle course at 24 weeks of
age.
(MP4)
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